Project Grant HT94252510511
Award Date
9/1/25
Completion Date
8/31/28
Dollars Obligated
$325K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Boston, MA 02109, USA
Similar Awards
The federal Project Grant award of $200,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will support research conducted by Northwestern University to elucidate the neural basis of hallucinations in Parkinson's disease. The award, effective July 1, 2025 through June 30, 2027, will enable Northwestern University's researchers to investigate this critical medical challenge and develop innovative solutions to transform healthcare for military...
The Defense Health Agency awarded a $490,602 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Ecole Polytechnique Federale De Lausanne (EPFL) in Switzerland. The grant, with a performance period from September 1, 2025 to August 31, 2028, will support the development of a clinical-grade spinal cord neuroprosthesis to alleviate locomotor deficits in people with Parkinson's disease. EPFL, a non-profit educational institution and state-controlled...
The Defense Health Agency awarded a $1,493,220 Project Grant to The Cleveland VA Medical Research & Education Foundation under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of a "Neurally Integrated Lower Limb Prosthesis for Home and Community Use" to aid mobility and sensory restoration for wounded veterans. The 4-year project, running from September 2023 to August 2027, aligns with the program's priorities of advancing...
This $2,000,000 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research on the interrelationship between the PINK1-PRKN pathway disruption and tauopathy in the pathophysiology of cognitive impairment in Parkinson's disease. The award, with a performance period from June 1, 2025 to May 31, 2028, was granted to the Board of Regents of the University of Nebraska, through its University of Nebraska Medical...
The Defense Health Agency awarded a $1,184,252 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Centre Hospitalier Universitaire Vaudois (Chuv) in Lausanne, Switzerland. The grant will fund the development of a clinical-grade spinal cord neuroprosthesis to alleviate locomotor deficits in people with Parkinson's disease. The award period runs from September 1, 2025 to August 31, 2028. Chuv is a non-profit hospital and research institution recognized...
The Defense Health Agency awarded a $199,966 project grant to the Ecole Polytechnique Federale De Lausanne (EPFL) in Switzerland under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the funding will be used to conduct research on the foundations supporting neuroprosthetic management of hypotensive complications in...
The Defense Health Agency awarded a $750,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Philadelphia Research And Education Foundation (PREF), a non-profit research organization, to develop tissue-engineered motor units with a preformed vascular network as an implantable composite tissue to augment neurovascular regeneration in volumetric muscle loss. The award period runs from July 15, 2024 to July 14, 2027. PREF has extensive experience...
The Project Grant award of $2,455,263 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by the Kessler Foundation, Inc. to investigate the use of transcutaneous spinal stimulation and gait training to improve mobility and motor control in individuals with traumatic brain injury. The award period runs from September 1, 2024 to August 31, 2028. As a leading center for rehabilitation research, the Kessler Foundation will conduct...
This $1,199,967 Project Grant awarded on September 1, 2023 by the Defense Health Agency supports research under the Military Medical Research and Development (CFDA 12.420) program. The primary award recipient, the University of Vermont & State Agricultural College, will investigate "Cognitive Functions Impairment as a Novel Paradigm for Delineating Cognitive Dysfunction in Parkinson's Disease". Two sub-awards were made to Case Western Reserve University and the Portland VA Research...
This Project Grant award of $2,163,115.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research conducted by Pathmaker Neurosystems Inc. to develop a noninvasive neuromodulation approach to slow the progression of amyotrophic lateral sclerosis (ALS) by suppressing neuronal hyperexcitability. The research, taking place in Boston, MA, aims to explore this innovative therapeutic method over the 2-year performance period...